PNC Financial Services Group Inc. Decreases Stock Holdings in Stryker Corporation $SYK

PNC Financial Services Group Inc. reduced its position in shares of Stryker Corporation (NYSE:SYK) by 3.2% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 997,458 shares of the medical technology company’s stock after selling 32,588 shares during the quarter. PNC Financial Services Group Inc.’s holdings in Stryker were worth $350,577,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. United Financial Planning Group LLC bought a new position in shares of Stryker during the 3rd quarter valued at approximately $27,000. CGC Financial Services LLC bought a new stake in Stryker during the fourth quarter valued at about $29,000. Strive Asset Management LLC bought a new stake in Stryker during the third quarter valued at about $30,000. ANTIPODES PARTNERS Ltd bought a new stake in Stryker during the third quarter valued at about $34,000. Finally, Copia Wealth Management boosted its position in Stryker by 181.6% during the third quarter. Copia Wealth Management now owns 107 shares of the medical technology company’s stock valued at $40,000 after purchasing an additional 69 shares in the last quarter. 77.09% of the stock is currently owned by institutional investors.

Stryker Trading Up 1.5%

Stryker stock opened at $317.81 on Wednesday. The company has a quick ratio of 1.25, a current ratio of 2.11 and a debt-to-equity ratio of 0.62. Stryker Corporation has a 52 week low of $281.00 and a 52 week high of $404.87. The company has a market capitalization of $121.84 billion, a price-to-earnings ratio of 36.78, a price-to-earnings-growth ratio of 1.97 and a beta of 0.80. The stock has a 50-day moving average price of $327.61 and a 200 day moving average price of $350.70.

Stryker (NYSE:SYK) last released its earnings results on Thursday, April 30th. The medical technology company reported $2.60 EPS for the quarter, missing analysts’ consensus estimates of $2.98 by ($0.38). Stryker had a return on equity of 23.42% and a net margin of 13.20%.The firm had revenue of $6.02 billion for the quarter, compared to analyst estimates of $6.34 billion. During the same period last year, the firm earned $2.84 EPS. The company’s revenue for the quarter was up 2.6% compared to the same quarter last year. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. Sell-side analysts anticipate that Stryker Corporation will post 14.98 EPS for the current year.

Stryker Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Tuesday, June 30th will be issued a dividend of $0.88 per share. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $3.52 dividend on an annualized basis and a dividend yield of 1.1%. Stryker’s payout ratio is 40.74%.

Analyst Ratings Changes

SYK has been the subject of a number of research analyst reports. Leerink Partners initiated coverage on Stryker in a research note on Monday, April 13th. They issued an “outperform” rating and a $410.00 price target for the company. Citigroup decreased their price target on Stryker from $420.00 to $385.00 and set a “buy” rating for the company in a research note on Tuesday, April 7th. Truist Financial reiterated a “hold” rating and issued a $330.00 price target (down from $380.00) on shares of Stryker in a research note on Monday, May 4th. Sanford C. Bernstein set a $410.00 price target on Stryker in a research note on Friday, May 1st. Finally, BTIG Research decreased their price target on Stryker from $397.00 to $379.00 and set a “buy” rating for the company in a research note on Friday, May 1st. Sixteen equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $395.48.

Insider Activity at Stryker

In related news, VP M Kathryn Fink sold 3,500 shares of Stryker stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $283.45, for a total transaction of $992,075.00. Following the completion of the sale, the vice president owned 177 shares of the company’s stock, valued at $50,170.65. The trade was a 95.19% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 4.60% of the stock is owned by company insiders.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.